Concord Biotech Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 341.43 | 288.22 | 260.49 |
| Operating Expense | 203.51 | 179.19 | 156.52 |
| Net Profit | 90.02 | 67.78 | 62.90 |
| Net Profit Margin | 26.37% | 23.52% | 24.15% |
| Earning Per Share | 8.60 | 6.48 | 6.01 |
| EBIDTA | 138.22 | 108.08 | 103.35 |
| Effective Tax Rate | 20.77% | 19.78% | 21.16% |
Particulars
Mar 2026
Revenue341.43
Operating Expense203.51
Net Profit90.02
Net Profit Margin26.37
Earning Per Share8.60
EBIDTA138.22
Effective Tax Rate20.77
